Primary thrombocytopenia
MONDO:0004680145 clinical trials for this condition and its sub-types, 27 tagged with Primary thrombocytopenia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Primary thrombocytopenia
-
Autoimmune thrombocytopenic purpura 95 trials
-
Evans syndrome 19 trials
-
New pill could help adults with low platelet disorder
Disease control CompletedThis Phase 3 trial tested an oral drug called HMPL-523 (sovleplenib) in 272 adults with chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. Participants who had not responded well to prior treatments received eith…
Phase 3 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug shows promise for Long-Term platelet control in rare bleeding disorder
Disease control CompletedThis phase 3 trial tested the long-term safety and effectiveness of efgartigimod, an IV drug, in 101 adults with primary immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. Participants received efgartigimod infusions over 52 w…
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
ITP study reveals hidden toll on brain and body
Knowledge-focused CompletedThis study looked at how chronic immune thrombocytopenia (ITP) affects thinking skills and fatigue in adults. Researchers measured brain function and inflammation using blood tests and questionnaires in 97 patients. The goal was to better understand these connections, not to test…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC